---
figid: PMC8095092__nihms-1691486-f0002
figtitle: 'Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: emphasis on
  ponatinib'
organisms:
- Homo sapiens
- Mus musculus
- Danio rerio
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
- Drosophila melanogaster
pmcid: PMC8095092
filename: nihms-1691486-f0002.jpg
figlink: /pmc/articles/PMC8095092/figure/F2/
number: F2
caption: Signaling pathway inhibition by ponatinib in chronic myeloid leukemia and
  cardiomyocytes. (A) Ponatinib inhibits all BCR–ABL-dependent phosphorylation and
  signaling events, leading to the reversal of pro-survival effects and activation
  of apoptosis in leukemic cells. (B) In cardiomyocytes, ponatinib rapidly inhibits
  prosurvival signaling pathways leading to cardiomyocytes apoptosis and cardiac dysfunction.
  BAX, BCL2 associated X protein; BAD, BCL2-antagonist of cell death; ERK, extracellular
  signal-regulated kinase; FOXO3A, forkhead box O3A; GAB2, GRB2-associated binding
  protein 1; GRB2, growth factor receptor-bound protein 2; MEK, mitogen-activated
  ERK kinase; PIP3, phosphatidylinositol trisphosphate; PI3K, phosphatidylinositol
  3-kinase; SOS, son of sevenless; STAT5, signal transducer and activator of transcription
  5.
papertitle: 'Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: emphasis on
  ponatinib.'
reftext: Anand Prakash Singh, et al. Int J Cardiol. ;316:214-221.
year: '2020'
doi: 10.1016/j.ijcard.2020.05.077
journal_title: International journal of cardiology
journal_nlm_ta: Int J Cardiol
publisher_name: ''
keywords: Ponatinib | Tyrosine kinase inhibitor | Cardiotoxicity | Cardio-oncology
automl_pathway: 0.9038701
figid_alias: PMC8095092__F2
figtype: Figure
redirect_from: /figures/PMC8095092__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8095092__nihms-1691486-f0002.html
  '@type': Dataset
  description: Signaling pathway inhibition by ponatinib in chronic myeloid leukemia
    and cardiomyocytes. (A) Ponatinib inhibits all BCR–ABL-dependent phosphorylation
    and signaling events, leading to the reversal of pro-survival effects and activation
    of apoptosis in leukemic cells. (B) In cardiomyocytes, ponatinib rapidly inhibits
    prosurvival signaling pathways leading to cardiomyocytes apoptosis and cardiac
    dysfunction. BAX, BCL2 associated X protein; BAD, BCL2-antagonist of cell death;
    ERK, extracellular signal-regulated kinase; FOXO3A, forkhead box O3A; GAB2, GRB2-associated
    binding protein 1; GRB2, growth factor receptor-bound protein 2; MEK, mitogen-activated
    ERK kinase; PIP3, phosphatidylinositol trisphosphate; PI3K, phosphatidylinositol
    3-kinase; SOS, son of sevenless; STAT5, signal transducer and activator of transcription
    5.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Zhx2
  - Mdk
  - ras
  - Hras
  - Kras
  - Rem1
  - Bcr
  - Abl1
  - Ephb2
  - Mapk1
  - Bcl2
  - Grb2
  - Gab2
  - Stat5a
  - Bcl2l1
  - Akt1
  - Ecm1
  - Ppp1r13b
  - Pik3ca
  - Bax
  - Nkx3-1
  - Foxo3
  - Bad
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - KRAS
  - HRAS
  - NRAS
  - BCR
  - RN7SL263P
  - ABL1
  - MTTP
  - DSP-AS1
  - ABL2
  - EPHB2
  - MAPK1
  - MAPK3
  - XYLT2
  - SOS1
  - SOS2
  - BCL2
  - GRB2
  - GAB2
  - STAT5A
  - STAT5B
  - BCL2L1
  - AKT1
  - AKT2
  - AKT3
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - BAX
  - FOXO3
  - BAD
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - rab1ab
  - bcr
  - bcl2a
  - grb2b
  - gab2
  - stat5a
  - ddx3xb
  - baxa
  - foxo3a
  - badb
  - Raf
  - Dsor1
  - Mtk
  - Ras64B
  - Ras85D
  - RhoGAP1A
  - Abl
  - Erk7
  - rl
  - Sos
  - Debcl
  - drk
  - Akt
  - Myb
  - Pi3K21B
  - Taf5
  - mid
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - cass
  - cml
---
